John R Mackey Selected Research

John R Mackey Research Topics

Disease

109	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2002
74	Neoplasms (Cancer) 01/2022 - 01/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 10/2004
9	Adenocarcinoma 07/2017 - 02/2002
8	Fatigue 01/2018 - 06/2007
7	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2006
6	Cardiotoxicity 01/2022 - 07/2011
5	Triple Negative Breast Neoplasms 10/2021 - 03/2011
5	Carcinoma (Carcinomatosis) 01/2014 - 05/2006
4	Heart Failure 03/2019 - 11/2009
4	Anemia 01/2016 - 08/2004
3	Disease Progression 01/2022 - 01/2010
3	Hypertension (High Blood Pressure) 01/2022 - 04/2011
3	Ventricular Remodeling 03/2017 - 08/2009
3	Carcinogenesis 01/2016 - 01/2010
3	Overweight 01/2016 - 11/2002
3	Lymphedema (Milroy Disease) 11/2012 - 10/2007
2	Inflammation (Inflammations) 01/2022 - 03/2019
2	Hypoxia (Hypoxemia) 10/2021 - 01/2018
2	Fibrosis (Cirrhosis) 01/2021 - 01/2021
2	Lymphoma (Lymphomas) 10/2020 - 10/2003
2	Liver Diseases (Liver Disease) 01/2020 - 01/2020
2	Sarcopenia 01/2016 - 04/2009
2	Stomach Neoplasms (Stomach Cancer) 05/2010 - 01/2005
2	Osteoporosis 02/2010 - 05/2005
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2008 - 01/2005
2	Hodgkin Disease (Hodgkin's Disease) 06/2008 - 07/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2007 - 09/2005
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2004 - 10/2003
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
19	Gemcitabine FDA Link 11/2021 - 01/2002
15	AnthracyclinesIBA 01/2022 - 08/2004
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
12	Equilibrative Nucleoside Transporter 1IBA 12/2019 - 01/2002
11	Hormones (Hormone)IBA 01/2022 - 05/2003
11	Docetaxel (Taxotere)FDA Link 01/2019 - 10/2004
10	Trastuzumab (Herceptin)FDA Link 01/2022 - 05/2007
8	Estrogen ReceptorsIBA 01/2022 - 06/2008
8	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 01/2002
8	taxaneIBA 01/2015 - 08/2004
7	human ERBB2 proteinIBA 01/2022 - 12/2006
7	Pharmaceutical PreparationsIBA 02/2021 - 02/2002
7	Biological ProductsIBA 03/2019 - 01/2005
7	NucleosidesIBA 01/2014 - 01/2002
6	ErbB Receptors (EGF Receptor)IBA 03/2017 - 12/2006
6	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2014 - 09/2005
6	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 04/2009 - 10/2004
5	Estrogens (Estrogen)FDA Link 01/2022 - 05/2005
5	Taxoids (Taxanes)IBA 05/2017 - 04/2008
4	Messenger RNA (mRNA)IBA 11/2021 - 05/2004
4	RNA (Ribonucleic Acid)IBA 10/2021 - 03/2011
4	Epirubicin (Ellence)FDA LinkGeneric 10/2021 - 04/2008
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2016 - 08/2010
4	Tamoxifen FDA LinkGeneric 02/2016 - 05/2005
4	beta-Aminoethyl Isothiourea (AET)IBA 01/2016 - 12/2007
4	Anastrozole (Arimidex)FDA LinkGeneric 02/2010 - 05/2005
4	Capecitabine (Xeloda)FDA Link 04/2009 - 01/2002
3	AmberIBA 03/2022 - 11/2012
3	Oxygen (Dioxygen)IBA 01/2022 - 06/2009
3	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 01/2005
3	AntibodiesIBA 01/2020 - 07/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 08/2003
3	TubulinIBA 05/2017 - 06/2007
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2015 - 03/2011
3	Progesterone Receptors (Progesterone Receptor)IBA 05/2011 - 08/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2011 - 06/2007
3	thiamine triphosphorate (TTP)IBA 04/2009 - 10/2004
2	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 10/2021 - 04/2016
2	UridineIBA 10/2021 - 04/2016
2	glycylpeptide N-tetradecanoyltransferaseIBA 02/2021 - 10/2020
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 01/2020
2	AntioxidantsIBA 01/2018 - 02/2016
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 03/2017 - 07/2011
2	MicroRNAs (MicroRNA)IBA 01/2016 - 09/2015
2	CytokinesIBA 09/2015 - 08/2006
2	Peptides (Polypeptides)IBA 08/2015 - 01/2002
2	RamucirumabIBA 01/2015 - 07/2010
2	Deoxycytidine KinaseIBA 01/2014 - 05/2004
2	Carboplatin (JM8)FDA LinkGeneric 01/2014 - 01/2011
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 11/2002
2	Bevacizumab (Avastin)FDA Link 10/2012 - 04/2011
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2012 - 08/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011 - 07/2010
2	Phosphotransferases (Kinase)IBA 11/2010 - 09/2005
2	Hemoglobins (Hemoglobin)IBA 11/2010 - 09/2008
2	Monoclonal AntibodiesIBA 11/2009 - 01/2002
2	fludarabineIBA 11/2008 - 01/2005
2	DeoxycytidineIBA 07/2007 - 05/2004
2	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2004 - 10/2003

Therapy/Procedure

56	Therapeutics 01/2022 - 01/2002
52	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
16	Adjuvant Chemotherapy 07/2021 - 09/2005
3	Caloric Restriction 10/2021 - 01/2018
3	Neoadjuvant Therapy 01/2019 - 04/2011
3	Combination Drug Therapy (Combination Chemotherapy) 01/2014 - 11/2002
2	Resistance Training 07/2021 - 09/2014
2	Palliative Care (Palliative Therapy) 01/2013 - 11/2008
2	Aftercare (After-Treatment) 11/2012 - 08/2002
2	Radiotherapy 04/2009 - 05/2003